Jacobi Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Jacobi Capital Management LLC

$1.29 Billion
Q3 2024

A detailed history of Jacobi Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jacobi Capital Management LLC holds 1,297 shares of REGN stock, worth $876,499. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,297

Previous 1,225 5.88%

Holding current value

$876,499

Previous $1.29 Million 5.91%

% of portfolio

0.11%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $73,734 - $86,526	72 Added 5.88%	1,297 $1.36 Million
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $75,955 - $92,122	86 Added 7.55%	1,225 $1.29 Million
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $18,053 - $19,867	20 Added 1.79%	1,139 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $82,169 - $93,460	106 Added 10.46%	1,119 $982,000
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $4,154 - $5,066	6 Added 0.6%	1,013 $833,000
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $315,713 - $374,487	-451 Reduced 30.93%	1,007 $723,000
Q1 2023 May 05, 2023	BUY	$680.49 - $826.97 $23,817 - $28,943	35 Added 2.46%	1,458 $1.2 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $2,117 - $2,299	-3 Reduced 0.21%	1,423 $1.03 Million
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $26,402 - $33,318	46 Added 3.33%	1,426 $982,000
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $112,411 - $151,462	205 Added 17.45%	1,380 $816,000
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $14,878 - $17,460	25 Added 2.17%	1,175 $821,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $10,869 - $13,419	20 Added 1.77%	1,150 $726,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $26,405 - $31,324	46 Added 4.24%	1,130 $684,000
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $486,984 - $575,296	1,030 Added 1907.41%	1,084 $605,000
Q1 2021 May 11, 2021	SELL	$446.73 - $548.2 $20,996 - $25,765	-47 Reduced 46.53%	54 $26,000
Q2 2020 Aug 04, 2020	BUY	$493.32 - $643.92 $31,572 - $41,210	64 Added 172.97%	101 $63,000
Q2 2020 Jul 27, 2020	SELL	$493.32 - $643.92 $31,572 - $41,210	-64 Reduced 63.37%	37 $63,000
Q1 2020 Apr 24, 2020	SELL	$336.18 - $494.43 $3,361 - $4,944	-10 Reduced 9.01%	101 $49,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $7,441 - $8,791	20 Added 21.98%	111 $46,000
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $30,549 - $35,540	87 Added 2175.0%	91 $37,000
Q4 2017 Feb 05, 2018	SELL	$358.63 - $469.95 $7,172 - $9,399	-20 Reduced 83.33%	4 $1,000
Q2 2017 Aug 10, 2017	BUY	N/A	24	24 $12,000

Others Institutions Holding REGN

# of Institutions

1,497

Shares Held

82.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Account

Jacobi Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History